Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients
Determination of IL-17, Bcl-3, AND IκBζ Expression Levels in the Gingival Crevicular Fluid of Psoriasis Patients
1 other identifier
observational
12
1 country
1
Brief Summary
This study aimed to compare the levels of IL-17 (interleukin- 17), Bcl-3 (B-cell lymphoma 3-encoded protein), and IκBζ (NF-kappa-B inhibitor zeta) in the gingival crevicular fluid of psoriatic and healthy individuals and the clinical parameters such as periodontal health, gingival index, plaque index and mobility (using periotest device)in the patient and control groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2023
CompletedFirst Submitted
Initial submission to the registry
April 15, 2024
CompletedFirst Posted
Study publicly available on registry
May 10, 2024
CompletedMay 10, 2024
May 1, 2024
2 months
April 15, 2024
May 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Level of Gene expression
In the real-time polymerase chain reaction (PCR) results of the β-actin gene, which was used as a housekeeping gene in the study, the automatic threshold value was determined by the device as 0.02. It was observed that all samples were above the threshold value and gave a ct value. According to the housekeeping gene, IL-17, IκBζ, and Bcl-3gene expression values were determined.
Sample collection during examination, approximately 2 months
Secondary Outcomes (4)
Plaque index
Baseline, week 2
Gingival index
Baseline, week 2
Clinical attachment level
Baseline, week 2
Tooth Mobility
Baseline, week 2
Study Arms (2)
Psoriasis patients
IL-17, Bcl-3, IκBζ gene expression levels were examined
Control group
IL-17, Bcl-3, IκBζ gene expression levels were examined
Interventions
Samples were taken from two mandibular molar teeth. Before sampling, the sites were isolated with cotton rolls and then carefully dried with an air syringe to avoid saliva contamination. GCF was collected using sterile periodontal strips by gently inserting them into the gingival sulcus or pocket until slight resistance was noticed. After 30 s, the strips were collected into sterile tubes and immediately transported to the laboratory for storage (-40 °C) and posterior analysis.
A periodontist conducted the periodontal evaluation, which included a comprehensive assessment of clinical periodontal status, a full mouth manual periodontal charting, measurement of probing depth, clinical attachment level, bleeding on probing, and evaluation of mobility using a periotest device. Additionally, information regarding the patient's smoking status, frequency of smoking, and oral hygiene habits was obtained.
Eligibility Criteria
The patients living in Eastern region of Turkey and visiting our clinic
You may qualify if:
- Patients previously diagnosed with psoriasis
- Adults who are 18 years of age or older
- Patients having at least 11 teeth
You may not qualify if:
- Patients with any known systemic disease other than psoriasis
- Patients who had received antibiotic, nonsteroidal anti-inflammatory, and/or immunomodulatory therapy within the last three months
- Patients who had received radiotherapy and/or chemotherapy within the last years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ayşe Gül Öner Talmaç
Kahramanmaraş, Onikişubat, 46000, Turkey (Türkiye)
Biospecimen
Gingival crevicular fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayşe Gül Öner Talmaç, PhD
Faculty of Dentistry, Kahraman Maraş Sütçü İmam University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
April 15, 2024
First Posted
May 10, 2024
Study Start
February 1, 2023
Primary Completion
April 10, 2023
Study Completion
August 15, 2023
Last Updated
May 10, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share